Common cannabimimetic pharmacophoric requirements between aminoalkyl indoles and classical cannabinoids
- 5 May 1995
- journal article
- Published by Elsevier in Life Sciences
- Vol. 56 (23-24) , 1963-1970
- https://doi.org/10.1016/0024-3205(95)00177-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Conformational Analysis of the Prototype Nonclassical Cannabinoid CP-47,497, Using 2D NMR and Computer Molecular ModelingJournal of Medicinal Chemistry, 1994
- Design, Synthesis and Pharmacology of Cannabimimetic IndolesBioorganic & Medicinal Chemistry Letters, 1994
- Conformationally restrained analogs of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptorJournal of Medicinal Chemistry, 1992
- Antinociceptive (aminoalkyl)indolesJournal of Medicinal Chemistry, 1991
- The molecular basis of cannabinoid activityLife Sciences, 1990
- The importance of the orientation of the C9 substituent to cannabinoid activityJournal of Medicinal Chemistry, 1989
- .alpha.2-Adrenergic agonists/antagonists: the synthesis and structure-activity relationships of a series of indolin-2-yl and tetrahydroquinolin-2-yl imidazolinesJournal of Medicinal Chemistry, 1987
- The Crystal and Molecular Structure of Delta9-Tetrahydrocannabinolic Acid B.Acta Chemica Scandinavica, 1975